Cancers, Vol. 12, Pages 2675: Deciphering the Role of Innate Immune NF- ĸB Pathway in Pancreatic Cancer

Cancers, Vol. 12, Pages 2675: Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer Cancers doi: 10.3390/cancers12092675 Authors: Namrata Khurana Paarth B. Dodhiawala Ashenafi Bulle Kian-Huat Lim Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with no effective treatment option. A predominant hallmark of PDAC is the intense fibro-inflammatory stroma which not only physically collapses vasculature but also functionally suppresses anti-tumor immunity. Constitutive and induced activation of the NF-κB transcription factors is a major mechanism that drives inflammation in PDAC. While targeting this pathway is widely supported as a promising therapeutic strategy, clinical success is elusive due to a lack of safe and effective anti-NF-κB pathway therapeutics. Furthermore, the cell type-specific contribution of this pathway, specifically in neoplastic cells, stromal fibroblasts, and immune cells, has not been critically appraised. In this article, we highlighted seminal and recent literature on molecular mechanisms that drive NF-κB activity in each of these major cell types in PDAC, focusing specifically on the innate immune Toll-like/IL-1 receptor pathway. We reviewed recent evidence on the signaling interplay between the NF-κB and oncogenic KRAS signaling pathways in PDAC cells and their collective contribution to cancer inflammation. Lastly, we reviewed clinical tria...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Review Source Type: research